Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors

scientific article published on 01 May 2000

Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.RES.86.10.1054
P698PubMed publication ID10827135

P2093author name stringH Zhang
S F Steinberg
A Sabri
E Pak
P Andrade-Gordon
A Darrow
G Muske
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)1054-1061
P577publication date2000-05-01
P1433published inCirculation ResearchQ2599020
P1476titleSignaling properties and functions of two distinct cardiomyocyte protease-activated receptors
P478volume86

Reverse relations

cites work (P2860)
Q42249248Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study
Q83225189Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation
Q89414548Attenuation of type-1 diabetes-induced cardiovascular dysfunctions by direct thrombin inhibitor in rats: a mechanistic study
Q44489645Ca2+ dynamics of thrombin-stimulated rat heart-derived embryonic myocytes: relationship to protein synthesis and cell growth.
Q89641851Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Q38046798Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?
Q41585571Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells
Q28068706Direct Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in Rats
Q47748648Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice
Q35786123Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility
Q54638672Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure.
Q35682585Effects of thrombin and thrombin receptor activation on cardiac function after acute myocardial infarction
Q43010737Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions.
Q40649188Expression and Cytoprotective Effect of Protease-activated Receptor-1 in Gastric Epithelial Cells
Q74353636G protein-coupled receptor kinases: gotta real kure for heart failure?
Q34226037G-proteins in growth and apoptosis: lessons from the heart
Q44409431Human eosinophils are activated by cysteine proteases and release inflammatory mediators
Q36517193Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
Q40631207MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2
Q34066783MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA.
Q36542806Matrix metalloproteases and PAR1 activation
Q38044254Mechanisms and consequences of inflammatory signaling in the myocardium
Q31133259Molecular mechanism of c-jun antisense gene transfection in alleviating injury of cardiomyocytes treated with burn serum and hypoxia
Q44411433Neutrophil Cathepsin G Promotes Detachment-induced Cardiomyocyte Apoptosis via a Protease-activated Receptor-independent Mechanism
Q36638187PAR-1 contributes to the innate immune response during viral infection.
Q34402844PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes
Q41649719Phos-tag SDS-PAGE resolves agonist- and isoform-specific activation patterns for PKD2 and PKD3 in cardiomyocytes and cardiac fibroblasts
Q55053632Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.
Q35060673Protease activated receptor-2 contributes to heart failure
Q39158447Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation
Q50002204Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.
Q90894947Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity
Q34222208Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.
Q37674817Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury
Q33765289Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy
Q36267482Protease-activated receptor-2 (PAR2) in cardiovascular system.
Q35064542Protease-activated receptors and myocardial infarction
Q35566719Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure
Q36733747Proteinase-activated receptors in the lower urinary tract
Q37024500Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
Q93111117Proteinase‑activated receptor 2 deficiency is a protective factor against cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury
Q35057155Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system.
Q37617543SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts
Q36405459Thrombin receptor and ventricular arrhythmias after acute myocardial infarction
Q26824050Tissue factor, protease activated receptors and pathologic heart remodelling
Q40649196Trypsin induces tumour necrosis factor-alpha secretion from a human leukemic mast cell line
Q42463329Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes.
Q92502671p38α MAPK inhibition translates to cell cycle re-entry of neonatal rat ventricular cardiomyocytes and de novo nestin expression in response to thrombin and after apex resection
Q40261518p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes
Q42219763β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.

Search more.